Association between Expression of ERCC1, XPA and 8092C>A of ERCC1, 5'UTR of XPA Polymorphisms and Clinical Response to Cisplatin-Based Chemotherapy and Survival in Patients with Non-Seminomatous Testicular Germ Cell Tumors.

被引：0
|
作者：
Mendoza, J. [1 ]
Hernandez, C. [1 ]
Martinez, J. [1 ]
Perez-Montiel, D. [1 ]
Castro, C. [1 ]
Fabian-Morales, E. [1 ]
Santibanez, M. [1 ]
Gonzalez-Barrios, R. [1 ]
Soto-Reyes, E. [1 ]
Diaz-Chavez, J. [1 ]
Onate, L. [1 ]
Jimenez, M. [1 ]
Nunez, M. [2 ]
Dyer, R. [2 ]
Herrera, L. A. [1 ]
机构：
[1] Natl Canc Inst, Mexico City, DF, Mexico
[2] Inst Nacl Enfermedades Neoplas, Lima, Peru
来源：
MOLECULAR BIOLOGY OF THE CELL | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
1632
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Polymorphisms in ERCC1 gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients
    Zhao, Xin
    Zhang, Zhiqiang
    Yuan, Yan
    Yuan, Xiaomei
    TUMOR BIOLOGY, 2014, 35 (08) : 8335 - 8341
  • [32] A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer
    Jian Cheng
    Minwen Ha
    Yadi Wang
    Jing Sun
    Junchen Chen
    Yue Wang
    Chunyan Tong
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 231 - 238
  • [33] A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with lat-stage non-small cell lung cancer
    Cheng, Jian
    Ha, Minwen
    Wang, Yadi
    Sun, Jing
    Chen, Junchen
    Wang, Yue
    Tong, Chunyan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (02) : 231 - 238
  • [34] ERCC1 immunohistochemical expression is related to histological differentiation and predicts objective response and disease-free survival in patients treated by cisplatin-based chemotherapy for locally advanced head and neck squamous-cell carcinoma
    Handra-Luca, Adriana
    Hernandez, Juana
    Mountzios, Giannis
    Taranchon, Estelle
    Lacau-St-Guily, Jean
    Soria, Jean-Charles
    Fouret, Pierre
    VIRCHOWS ARCHIV, 2007, 451 (02) : 461 - 461
  • [35] Lack of correlation between ERCC1 (C8092A) Single Nucleotide Polymorphism and efficacy/toxicity of platinum based chemotherapy in Chinese patients with advanced Non-Small Cell Lung Cancer
    KimCurran, V
    Zhou, C.
    Schmid-Bindert, G.
    Ren, Shengxiang
    Zhou, S.
    Zhang, L.
    Zhang, J.
    ADVANCES IN MEDICAL SCIENCES, 2011, 56 (01): : 30 - 38
  • [36] ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer
    Booton, Richard
    Ward, Tim
    Ashcroft, Linda
    Morris, Julie
    Heighway, Jim
    Thatcher, Nick
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (10) : 902 - 906
  • [37] ERCC1 protein expression is not associated with survival after platinum-based chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC)
    Pennell, Nathan A.
    Chirieac, Lucian R.
    El Karak, Fadi
    Lynch, Thomas J.
    Heist, Rebecca S.
    Christiani, David C.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : S238 - S239
  • [38] Expression of ERCC1 and BRCA1 predict the clinical outcome of non-small cell lung cancer in patients receiving platinum-based chemotherapy
    Wang, T. B.
    Zhang, N. L.
    Wang, S. H.
    Li, H. Y.
    Chen, S. W.
    Zheng, Y. G.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (02) : 3704 - 3710
  • [39] SINGLE NUCLEOTIDE POLYMORPHISMS IN DNA REPAIR GENE ERCC1 PREDICT CLINICAL RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN NON-SMALL CELL LUNG CANCER
    Xu, Lin
    Ren, Binhui
    Li, Ming
    Yang, Xin
    Jiang, Feng
    Yin, Rong
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1303 - S1304
  • [40] Predictive effects of RRM1, ERCC1, XRCC3, BRCA1 and EGFR genotyping or expression for clinical outcome of advanced NSCLC patients treated with cisplatin-based chemotherapy or gefitinib
    Zhou, Caicun
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (05) : 321 - 322
12345